BeiGene

Yahoo Finance • 6 days ago

Did FDA Fast-Track HER2 Regimen Just Shift BeOne Medicines' (ONC) Investment Narrative?

On 29 April 2026, BeOne Medicines announced that the FDA granted Priority Review to an sBLA for TEVIMBRA with ZIIHERA and chemotherapy, alongside Breakthrough Therapy Designation for ZIIHERA-based regimens in first-line treatment of unrese... Full story

Yahoo Finance • 26 days ago

Here are the major earnings after the close Wednesday

Major earnings expected after the bell on Wednesday include: * SL Green Realty Corp. (SLG [https://seekingalpha.com/symbol/SLG]) * J.B. Hunt Transport Services (JBHT [https://seekingalpha.com/symbol/JBHT]) * BeOne Medicines AG (ONC... Full story

Yahoo Finance • 27 days ago

BeiGene Q1 2026 Earnings Preview

* BeiGene (ONC [https://seekingalpha.com/symbol/ONC]) is scheduled to announce Q1 earnings results on Wednesday, April 15th, after market close. * The consensus EPS Estimate is $0.85 [https://seekingalpha.com/symbol/ONC/earnings/estima... Full story

Yahoo Finance • last month

BeOne wins China approval for Amgen’s lung cancer drug Imdelltra

[Approved stamp on application form or business agreement document] * BeOne Medicines (ONC [https://seekingalpha.com/symbol/ONC]) announced on Friday that Chinese officials granted conditional approval for tarlatamab, a bispecific T-cel... Full story

Yahoo Finance • last month

BeOne Medicines price target lowered to $411 from $412 at Truist

Truist lowered the firm’s price target on BeOne Medicines (ONC) to $411 from $412 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 earnings in Biotech. Reactivity to regulatory and policy shifts across... Full story

Yahoo Finance • last month

Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating

BeOne Medicines AG (NASDAQ:ONC) is one of the 7 Fastest Growing European Stocks to Invest In. On March 26, 2026, Wolfe Research analyst Kalpit Patel initiated coverage on BeOne Medicines AG (NASDAQ:ONC) with an Outperform rating and a $34... Full story

Yahoo Finance • 2 months ago

This Fintech Stock Is Up 21% in a Year as Profits Surge, but One Fund's Nearly $300 Million Sale Cut Its Stake in Half

On February 17, 2026, HHLR Advisors reported selling 1,607,930 shares of Futu Holdings(NASDAQ:FUTU), an estimated $276.00 million transaction based on quarterly average pricing. What happened According to a Securities and Exchange Commis... Full story

Yahoo Finance • 2 months ago

BeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment

BeOne Medicines AG (NASDAQ:ONC) is among the 12 best stocks to buy and hold for the next 2 years. On February 26, BeOne Medicines AG (NASDAQ:ONC) reported total global revenues of $1.5 billion for the fourth quarter of 2025 and $5.3 billi... Full story

Yahoo Finance • 2 months ago

BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership

Total global revenues of $1.5 billion and $5.3 billion for the fourth quarter and full year, increases of 33% and 40% from the prior-year periods Global BRUKINSA (zanubrutinib) revenues of $1.1 billion and $3.9 billion for the fourth quart... Full story

Yahoo Finance • 3 months ago

HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model

Key Points HHLR Advisors, Ltd sold 1,641,000 shares of Baidu; estimated trade size was $216.23 million based on average pricing for the quarter Quarter-end position value declined by $216.23 million, reflecting both the share sale and cha... Full story

Yahoo Finance • 4 months ago

Strong Momentum Lifted BeOne Medicines AG (ONC) in Q3

Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2025 investor letter for the “Baird Chautauqua International and Global Growth Fund”. A copy of the letter c... Full story

Yahoo Finance • 5 months ago

A Fresh Look at BeOne Medicines (ONC) Valuation as Shares Gain Momentum

BeOne Medicines (ONC) shares saw a modest 2% bump in the latest trading session. Investors have been keeping an eye on the company's progress, especially given its ongoing focus on innovative cancer therapies and recent leadership moves.... Full story

Yahoo Finance • 5 months ago

Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied

Novo Nordisk stock jumped Wednesday on a lighter-than-feared discount for Ozempic and Wegovy under the Inflation Reduction Act. Continue Reading View Comments... Full story

Yahoo Finance • 5 months ago

U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

If approved, sonrotoclax will become the first BCL2 inhibitor for R/R MCL in the U.S., addressing a high unmet need in an aggressive cancer Sonrotoclax previously received Breakthrough Therapy Designation based on clinically meaningful, r... Full story

Yahoo Finance • 5 months ago

US Stock Market Today: S&P 500 Futures Slip as Rate Cut Bets Rise Amid Weak Jobs Data

The Morning Bull - US Market Morning Update Tuesday, Nov, 25 2025 US stock futures are slipping this morning, with S&P 500 contracts down around 0.1 percent. The key factor driving the mood is a drop in the 10-year Treasury yield to 4.04... Full story

Yahoo Finance • 6 months ago

Zymeworks shifts to a royalty-driven business model

[Golden Percentage Symbol] fatido Zymeworks (ZYME [https://seekingalpha.com/symbol/ZYME]) on Tuesday announced plans to focus on a royalty-driven growth model backed by its internal R&D engine and licensing arrangements with companies suc... Full story

Yahoo Finance • 6 months ago

Jazz, Zymeworks’ Ziihera trial shows significant PFS improvement, shares rally

[Biomedical Researchers Conduct Experiments in a Modern Laboratory. Female Scientist Preparing a Set of Samples in Test Tubes with Purple Caps. Colleague Analyzes Data on a Computer in the Background] gorodenkoff/iStock via Getty Images... Full story

Yahoo Finance • 6 months ago

Saudi sovereign wealth fund cuts holdings of U.S. stocks

[World Map with Saudi Arabia Flag Overlay] Hacer Keles/iStock via Getty Images Saudi Arabia’s Public Investment Fund trimmed its exposure to U.S. equities in the third quarter, shedding stakes in nearly a dozen American companies and push... Full story

Yahoo Finance • 6 months ago

Stock Market Today: Dow Hits New Highs; Lilly, Barrick, Goldman Break Out (Live Coverage)

Stock Market Today: The Dow Jones index rose Wednesday to new highs and AMD rallied sharply. Gold and silver stocks jammed. Continue Reading View Comments... Full story

Yahoo Finance • 6 months ago

IBD Stock Of The Day BeOne Breaks Out As It Takes On Cancer Giants J&J, AbbVie

BeOne Medicines is Wednesday's IBD Stock Of The Day. The IBD 50 biotech is breaking out after a record-breaking quarter. Continue Reading View Comments... Full story